| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/17/1997 | WO1996040263A3 Semicarbazide-containing linker compounds for formation of stably-linked conjugates and methods related thereto |
| 04/17/1997 | CA2491511A1 Prolonged release of gm-csf |
| 04/17/1997 | CA2234666A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 04/17/1997 | CA2231647A1 Fast drying, film forming iodine release solution |
| 04/17/1997 | CA2231273A1 A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface |
| 04/16/1997 | EP0767839A1 Improvements in or relating to delivery of nucleic acids |
| 04/16/1997 | EP0767819A1 pH-MODIFIED BIOCOMPATIBLE MONOMER AND POLYMER COMPOSITIONS |
| 04/16/1997 | EP0767673A1 Methods for reduced renal uptake of antibody fragments |
| 04/16/1997 | EP0767669A1 New pharmaceutical preparation for pain management |
| 04/16/1997 | EP0767667A2 USE OF $g(b)GalNac(1-4)$g(b)Gal CONJUGATES TO TREAT CANDIDA INFECTION |
| 04/16/1997 | EP0767663A1 Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide |
| 04/16/1997 | EP0767659A1 Transdermal administration of oxybutynin |
| 04/16/1997 | EP0767656A1 Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material |
| 04/16/1997 | EP0767634A1 Microcapsules for administration of neuroactive agents |
| 04/16/1997 | EP0656780B1 Drugs containing diphosphonic acids and salts thereof |
| 04/16/1997 | EP0620727B1 Cryopelleted moulded bodies, containing plant active substance extract and the pharmaceutical or cosmetic use of such pellets |
| 04/16/1997 | EP0584126B1 Penetration-promoting substance |
| 04/16/1997 | EP0514515B1 Anthracycline-conjugates |
| 04/16/1997 | CN1147377A Penicillin menstruum for injection |
| 04/16/1997 | CN1034557C Composition based on absorbable precipitate SiO2 |
| 04/15/1997 | WO1999017805A1 Bioactive derivatives of camptothecin |
| 04/15/1997 | US5621094 Method of preserving agarose gel structure during dehydration by adding a non-reducing glycoside of a straight-chain sugar alcohol |
| 04/15/1997 | US5621083 Immunotoxins comprising ribosome-inactivating proteins |
| 04/15/1997 | US5621078 Modified pseudomonas exotoxin PE40 |
| 04/15/1997 | US5621006 Topically applying in a vehicle, e.g. hydroxyacids, ketoacids and salts, esters thereof |
| 04/15/1997 | US5621005 Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives |
| 04/15/1997 | US5621002 Having a modified competitive enzyme activity inhbitor linked to a spacer-drug; enzyme cleavage at a lower concentration, i.e. low michaelis-menten constant(km) |
| 04/15/1997 | US5620970 Stable mixture containing enzyme inhibitor and (poly)ethoxylated castor oil; glaucoma, occular hypertension |
| 04/15/1997 | US5620962 Mixed with one of contaminant selected from, chlorophyll, carotenoid, phosphatidyl choline and diacylglyceryl-n,n,n-trimethylhomoserine and a vehicle; topical dermal administeration |
| 04/15/1997 | US5620902 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 04/15/1997 | US5620901 Determination of concentration by affinity titration |
| 04/15/1997 | US5620885 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 04/15/1997 | US5620884 Modified polyether |
| 04/15/1997 | US5620858 Method of removing shiga-like toxins from biological samples |
| 04/15/1997 | US5620844 Assays for detecting hepatitis B virus envelope antigens or antibodies thereto and diagnostic test kits for use in performing the assays |
| 04/15/1997 | US5620708 Compositions and methods for the oral delivery of active agents |
| 04/15/1997 | US5620706 Polyionic insoluble hydrogels comprising xanthan and chitosan |
| 04/15/1997 | US5620700 Injectable drug delivery system and method |
| 04/15/1997 | US5620698 Blends of absorbable polyoxaesters containing amines and/or amido groups |
| 04/15/1997 | US5620689 Administering a suspension of liposomes having a surface coating of polyethylene glycol chains |
| 04/15/1997 | US5620686 Antigen-antibody conjugates |
| 04/15/1997 | US5620013 Method for destroying residual lens epithelial cells |
| 04/15/1997 | US5619984 Dry powder inhalation device having a powder-loaded elongate carrier |
| 04/15/1997 | CA2006398C Transdermal therapeutical system comprising physostigmine as active component and process for the production thereof |
| 04/10/1997 | WO1997012989A1 Biologically-active polymers |
| 04/10/1997 | WO1997012912A1 Peptides usable as vectors for the intracellular addressing of active molecules |
| 04/10/1997 | WO1997012899A1 S-dC28 AS AN ANTIRESTENOSIS AGENT AFTER BALLOON INJURY |
| 04/10/1997 | WO1997012852A1 Semi-fluorinated alkanes and their use |
| 04/10/1997 | WO1997012632A1 Methods for treatment of diseases associated with a deficiency of fas ligand activity |
| 04/10/1997 | WO1997012626A1 Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing the said preparation |
| 04/10/1997 | WO1997012624A1 Novel peptides |
| 04/10/1997 | WO1997012618A1 Gel for the local hormonotherapy of vaginal dryness |
| 04/10/1997 | WO1997012608A1 External antiinflammatory agent |
| 04/10/1997 | WO1997012605A1 Controlled release matrix for pharmaceuticals |
| 04/10/1997 | WO1997012603A1 Solid medicaments obtained by extrusion of an isomalt-containing polymer-active substance melt |
| 04/10/1997 | WO1997012602A1 Stimulation of hair follicles |
| 04/10/1997 | WO1997012601A2 Gel formulations containing growth factors |
| 04/10/1997 | WO1997012600A1 Unit galenical form for local hormonotherapy of vaginal dryness |
| 04/10/1997 | WO1997012594A1 Topical composition containing a silicone-grafted polymer and an amine silicone and/or a silicone gum or resin |
| 04/10/1997 | WO1997012581A2 Novel composition containing an acid-labile omeprazole and process for its preparation |
| 04/10/1997 | WO1997012580A2 Novel composition containing an acid-labile benzimidazole and process for its preparation |
| 04/10/1997 | WO1997007139A3 Stabilized chitin derivative compounds |
| 04/10/1997 | WO1997006798A3 Pharmaceutical formulations |
| 04/10/1997 | DE19537012A1 Cyclosporin(e) enhaltende pharmazeutische Zubereitung zur oralen Applikation und Verfahren zu ihrer Herstellung A cyclosporin (s) enhaltende pharmaceutical preparation for oral administration and processes for their preparation |
| 04/10/1997 | CA2233923A1 Gel for the local hormonotherapy of vaginal dryness |
| 04/10/1997 | CA2233919A1 Unit galenical form for local hormonotherapy of vaginal dryness |
| 04/10/1997 | CA2233272A1 Novel peptides |
| 04/10/1997 | CA2233059A1 Biologically-active polymers |
| 04/10/1997 | CA2223005A1 Topical composition containing a silicone-grafted polymer and an amine silicone and/or a silicone gum or resin |
| 04/10/1997 | CA2207084A1 Controlled release matrix for pharmaceuticals |
| 04/09/1997 | EP0766960A1 External preparations for treating dermatoses |
| 04/09/1997 | EP0766689A1 Novel oligosaccharide derivatives, preparation method therefor and uses thereof |
| 04/09/1997 | EP0766661A1 Polyolpolyhydroxystearates |
| 04/09/1997 | EP0766570A1 Methods for treating respiratory disease |
| 04/09/1997 | EP0766566A1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 04/09/1997 | EP0766564A1 Controlled release polypeptide compositions and methods of treating inflammatory bowel disease |
| 04/09/1997 | EP0766557A1 Topical compositions comprising n-acetyl-l-cysteine |
| 04/09/1997 | EP0766556A1 Volume-expandable flat article suitable for use as an active substance carrier, in particular for oral use |
| 04/09/1997 | EP0766554A1 Polymer microparticles for drug delivery |
| 04/09/1997 | EP0693878B1 Iodine barrier teat dip |
| 04/09/1997 | EP0664696B1 Sustained release compositions for treating periodontal disease |
| 04/09/1997 | EP0625911B1 Malaria treatments |
| 04/09/1997 | EP0537292B1 Water insoluble derivatives of hyaluronic acid |
| 04/09/1997 | EP0506976B1 Combination of hyaluronic acid with medicinal ingredient and production thereof |
| 04/09/1997 | EP0436667B1 Biodegradable in-situ forming implants |
| 04/08/1997 | US5618850 Hydroxy-acid cosmetics |
| 04/08/1997 | US5618840 Prevention growth of helicobacter |
| 04/08/1997 | US5618803 Targeted drug delivery via phosphonate derivatives |
| 04/08/1997 | US5618800 Thermally-gelling drug delivery vehicles containing cellulose ethers |
| 04/08/1997 | US5618799 Storage stability, noncaking, nonscattering, adhesion |
| 04/08/1997 | US5618563 Encapsulating an anesthetic drug into biocompatiable microparticles |
| 04/08/1997 | US5618559 Method of making modified-release metronidazole compositions |
| 04/08/1997 | US5618555 Percutaneous absorption preparation |
| 04/08/1997 | US5618553 Contacting localized region of eye with polymer implant having reversibly associated modulating agent which is released at rate such that target cells are primarily affected |
| 04/08/1997 | US5618550 Method for treatment of abnormal conditions of the epithelium of bodily orifices |
| 04/08/1997 | US5618539 Aqueous solution comprising a heat resist stabilizer lysine or/and arginine |
| 04/08/1997 | US5618534 Isolated antigen endo glyx-1 |
| 04/08/1997 | US5618531 Method for increasing the viability of cells which are administered to the brain or spinal cord |
| 04/08/1997 | US5618528 Biologically compatible linear block copolymers of polyalkylene oxide and peptide units |
| 04/08/1997 | CA2137164C A new composition containing selegiline |